drugset / Trial / NCT02281643
Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
Phase 2
Completed
200 enrolled
Kwame Nkrumah University of Science and Technology
Heinrich-Heine University, Duesseldorf · collabUniversity of Bonn · collab
RandomizedCrossoverOpen-labelPrevention
Summary
This study will determine the influence of doxycycline treatment against Wolbachia/M. perstans on immunity against concomitant mycobacterial infections in healthy M. perstans infected individuals. In this regard, the investigators will perform a community-based randomized controlled trial (Phase 2a) in Asante Akim North District. A cohort of 200 participants who are contacts of patients with Tuberculosis or Buruli ulcer, of both sexes with no clinical condition requiring long-term medication but connected with Mansonella perstans will be investigated for the effect of doxycycline on microfilaria, the immune response and development of mycobacterial disease.
Timeline
- Start
- 2014-10
- Primary completion
- 2017-03-15
- Completion
- 2017-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxycycline | Small molecule | 200 mg | Oral |